News

Other news

3 December 2019

Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.

Read full story

Other news

8 October 2019

Cyprio Wins Women Startup Challenge Europe HealthTech

Read full story

Other news

28 August 2019

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

Read full story

Other news

16 August 2019

CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device

Read full story

Other news

12 August 2019

binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health

Read full story

Other news

23 July 2019

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story

Other news

17 July 2019

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story

Other news

17 July 2019

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story

Other news

11 June 2019

Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38

Read full story

Other news

6 April 2019

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story

Other news

26 March 2019

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story

Other news

9 January 2019

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

Read full story

Other news

3 January 2019

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Read full story